1.8(top 50%)
impact factor
4.1K(top 5%)
papers
85.8K(top 5%)
citations
101(top 5%)
h-index
1.8(top 50%)
impact factor
5.5K
all documents
88.7K
doc citations
143(top 5%)
g-index

Top Articles

#TitleJournalYearCitations
1Efficient production of high specific activity 64Cu using a biomedical cyclotronNuclear Medicine and Biology1997472
2Quantitation of 211At in small volumes for evaluation of targeted radiotherapy in animal modelsNuclear Medicine and Biology1995441
3Anatomy of SUVNuclear Medicine and Biology2000419
4Standardized methods for the production of high specific-activity zirconium-89Nuclear Medicine and Biology2009369
5Copper radionuclides and radiopharmaceuticals in nuclear medicineNuclear Medicine and Biology1996361
6Graphical analysis of PET data applied to reversible and irreversible tracersNuclear Medicine and Biology2000361
7Serotonin-1A receptor imaging in recurrent depression: replication and literature reviewNuclear Medicine and Biology2007341
8PET imaging with 89Zr: From radiochemistry to the clinicNuclear Medicine and Biology2013338
9FDG Accumulation and Tumor BiologyNuclear Medicine and Biology1998320
10O-(2-[18F]fluoroethyl)-l-tyrosine: uptake mechanisms and clinical applicationsNuclear Medicine and Biology2006317
11PET and [18F]-FDG in oncology: A clinical updateNuclear Medicine and Biology1996249
12Characterization of acetate metabolism in tumor cells in relation to cell proliferation: Acetate metabolism in tumor cellsNuclear Medicine and Biology2001235
13Development of radioimmunotherapeutic and diagnostic antibodies: an inside-out viewNuclear Medicine and Biology2007222
14In vivo biodistribution and accumulation of 89Zr in miceNuclear Medicine and Biology2011221
15F-18 Polyethyleneglycol stilbenes as PET imaging agents targeting Aβ aggregates in the brainNuclear Medicine and Biology2005217
1611C-labeled stilbene derivatives as Aβ-aggregate-specific PET imaging agents for Alzheimer’s diseaseNuclear Medicine and Biology2003212
17Radiosynthesis of 3′-deoxy-3′-[18F]fluorothymidine: [18F]FLT for imaging of cellular proliferation in vivoNuclear Medicine and Biology2000210
1818F-labeled RGD peptide: initial evaluation for imaging brain tumor angiogenesisNuclear Medicine and Biology2004208
19Fluorinated benzamide neuroleptics—III. Development of (S)-N-[(1-allyl-2-pyrrolidinyl)methyl]-5-(3-[18F]fluoropropyl)-2,3-dimethoxybenzamide as an improved dopamine D-2 receptor tracerNuclear Medicine and Biology1995206
20[18F]Fluoroazomycinarabinofuranoside (18FAZA) and [18F]Fluoromisonidazole (18FMISO): a comparative study of their selective uptake in hypoxic cells and PET imaging in experimental rat tumorsNuclear Medicine and Biology2003205
21Synthesis and Preliminary Evaluation of 9-(4-[18F]-Fluoro-3-Hydroxymethylbutyl)Guanine ([18F]FHBG): A New Potential Imaging Agent for Viral Infection and Gene Therapy Using PETNuclear Medicine and Biology1998203
22Assays for noninvasive imaging of reporter gene expressionNuclear Medicine and Biology1999203
23In vivo tracking of 111In-oxine labeled mesenchymal stem cells following infusion in patients with advanced cirrhosisNuclear Medicine and Biology2011202
24A comparative study of N.C.A. Fluorine-18 labeling of proteins via acylation and photochemical conjugationNuclear Medicine and Biology1996201
25Radiotracer synthesis from [11C]-iodomethane: a remarkably simple captive solvent methodNuclear Medicine and Biology2000194
26Column-switching HPLC for the analysis of plasma in PET imaging studiesNuclear Medicine and Biology2000191
27Models and methods for derivation of in vivo neuroreceptor parameters with PET and SPECT reversible radiotracersNuclear Medicine and Biology2001191
28Technetium-99m-labeled receptor-specific small-molecule radiopharmaceuticals: Recent developments and encouraging resultsNuclear Medicine and Biology1997189
29Pharmacokinetics and tumor retention of 125I-labeled RGD peptide are improved by PEGylationNuclear Medicine and Biology2004188
30Microfluidics in radiopharmaceutical chemistryNuclear Medicine and Biology2013188
31New directions in the coordination chemistry of 99mTc: a reflection on technetium core structures and a strategy for new chelate designNuclear Medicine and Biology2005183
32Cost-effectiveness of PET imaging in clinical oncologyNuclear Medicine and Biology1996182
33Serotonin type-1A receptor imaging in depressionNuclear Medicine and Biology2000182
34Radiosynthesis and initial evaluation of [18F]-FEPPA for PET imaging of peripheral benzodiazepine receptorsNuclear Medicine and Biology2008181
35Comparison of 18F-FET and 18F-FDG PET in brain tumorsNuclear Medicine and Biology2009177
36Radiolabeled peptide conjugates for targeting of the bombesin receptor superfamily subtypesNuclear Medicine and Biology2005169
37Synthesis of the enantiomers of [N-methyl-11C]PK 11195 and comparison of their behaviours as radioligands for PK binding sites in ratsNuclear Medicine and Biology1994164
38Regional distribution of serotonin transporter protein in postmortem human brainNuclear Medicine and Biology2005163
39Consensus nomenclature rules for radiopharmaceutical chemistry — Setting the record straightNuclear Medicine and Biology2017162
40The in vivo behavior of copper-64-labeled azamacrocyclic complexesNuclear Medicine and Biology1998155
41Tryptophan metabolism in breast cancers: molecular imaging and immunohistochemistry studiesNuclear Medicine and Biology2012154
422-((2-((dimethylamino)methyl)phenyl)thio)-5-iodophenylamine (ADAM): an improved serotonin transporter ligandNuclear Medicine and Biology2000151
43Fluorine-18-labeled fluorine gas for synthesis of tracer moleculesNuclear Medicine and Biology1997150
44In vitro and in vivo characterisation of [11C]-DASB: a probe for in vivo measurements of the serotonin transporter by positron emission tomographyNuclear Medicine and Biology2002150
45[11C]DAA1106: radiosynthesis and in vivo binding to peripheral benzodiazepine receptors in mouse brainNuclear Medicine and Biology2003144
46Evaluation of anesthesia effects on [18F]FDG uptake in mouse brain and heart using small animal PETNuclear Medicine and Biology2004144
47Detection of bony metastases of androgen-independent prostate cancer by PET-FDGNuclear Medicine and Biology1996140
48High purity production and potential applications of copper-60 and copper-61Nuclear Medicine and Biology1999140
49Comparison of simplified quantitative analyses of FDG uptakeNuclear Medicine and Biology2000140
50Comparison of fluorotyrosines and methionine uptake in F98 rat gliomasNuclear Medicine and Biology2003139